| 000 -LEADER |
|---|
| fixed length control field |
00598nam a2200205Ia 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240424141855.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
180712s9999 xx 000 0 und d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780857110848 |
| 041 ## - LANGUAGE |
|---|
| Language of text/sound track |
English |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.1342 |
| Author Mark |
BRI |
| DDC Edition number |
23 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Medical Association |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
BRITISH National Formulary 65: March 2013-September 2013/ |
| Statement of responsibility, etc. |
by British Medical Association and Royal Pharmaceutical Society |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
London |
| Name of publisher, distributor, etc. |
B M J Group |
| Date of publication, distribution, etc. |
2013 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xviii, 1102 p. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Includes indexes. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
BNF |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Formulary |
| 9 (RLIN) |
7351 |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drugs |
| 9 (RLIN) |
5054 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| item type |
Books in Reference (R) |
